Ambulatory Infusion Therapy Services Market Forecast (2024-2031), Size
The Ambulatory Infusion Therapy Services Market is expected to register a CAGR of 4.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Hospital-Based Ambulatory Surgery Centers, Free-Standing Ambulatory Surgery Centers). The report is further segmented based on Specialty (Single- Specialty Centers, Multi-Specialty Centers). The report further presents analysis based on Treatment (Cataract Surgery, Orthopaedic Surgery, Endoscopic Procedure, Gastroenterology, and Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Ambulatory Infusion Therapy Services Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Ambulatory Infusion Therapy Services Market Segmentation
Type- Hospital-Based Ambulatory Surgery Centers
- Free-Standing Ambulatory Surgery Centers
- Single- Specialty Centers
- Multi-Specialty Centers
- Cataract Surgery
- Orthopaedic Surgery
- Endoscopic Procedure
- Gastroenterology
- Others
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Ambulatory Infusion Therapy Services Market Growth Drivers- Shift to Home-Based Care: One of the primary factors shaping the ambulatory infusion therapy market is the increase and shift towards home healthcare services. With the evolution of the healthcare system towards cost reduction and better health outcomes for patients, there is great emphasis on delivering services within the home setting instead of in the hospital. This not only makes the patients comfortable but also lessens the pressure on the healthcare facilities..
- Growing Demand for Chronic Disease Management: The demand for infusion therapies is strongly associated with the rising incidences of chronic conditions such as diabetes, cancer, autoimmune diseases, and many others. These patients usually require long-term treatment plans and necessitate infusion therapy that can be effectively managed through ambulatory services. The ability to administer complex therapies outside the hospital setting is becoming increasingly essential for managing these chronic conditions..
- Cost-Effectiveness: Ambulatory infusion therapy services are more economical than inpatient care services. Treatment costs can be lowered due to reduced hospital stays and associated costs. This appeal of cost-effectiveness to both the patient and the payer perspectives has been a driving factor in the growth of this market, considering that healthcare systems look towards solutions that reduce costs and improve service delivery efficiency.
- Integration of Telehealth and Remote Monitoring: There will be a rise in the adoption of integrated telehealth solutions with ambulatory infusion services. Remote monitoring devices will allow healthcare users to assess how patients are progressing and manage treatments without being present. This ability not only improves the safety of patients but also makes it possible to undertake procedures whenever required, hence improving the effectiveness of treatment as a whole.
- Technological Innovations in Infusion Devices: Technological advancements, such as the development of smart infusion pumps and wearable devices, will be instrumental to the growth of this market. Such devices will include functionality for automatic dosing scheduling, real-time information transfer, and alerts for potential complications, thereby ensuring the safety and effectiveness of infusion therapies. Efforts will be made towards developing products that are user-friendly devices that most patients and caregivers can use with minimal training.
- Personalized Medicine and Tailored Therapies: The increasing prominence of personalized medicine will have a direct impact on the growth of the ambulatory infusion therapy market. Increasingly, healthcare centers are beginning to embrace ways of providing services that are centered on the individual patient, which means that infusion treatment will be tailored according to genetic, environmental, and lifestyle factors. The purpose is to enhance the treatment results and reduce side effects, thus facilitating better patient recovery.
- Improved Patient Education and Involvement: With the recent shifts, patients have started to take an active part in their healthcare decisions, emphasizing intensified patient education and engagement in infusion therapies. This will require the healthcare providers to come up with a wide educational package that will assist patients in choosing treatment methods, undertaking therapy, and controlling side effects. Involving the patients in their treatment will motivate them and ensure more adherence and satisfaction.
- Patient-Centric Care Models: There is an increased focus on patient-centric care, which puts patients' interests and preferences first. This is especially true for ambulatory infusion therapy, as it integrates the designs of treatment that encourage the involvement of patients more in the care process. Providers focusing on patient improvement and enhancement of the patient's experience will be in demand more than ever for their services.
- Growth of Home Infusion Services: Moving on to home infusion therapy is a significant opportunity for caregivers. In view of the fact that the Centers for Medicare & Medicaid Services (CMS) has widened the coverage for home infusion therapy, the potential for services that facilitate the administration of intravenous or subcutaneous medications to patients in the comfort of their homes has progressed. This will more likely continue, as patients tend to favor home-based care more rather than being in a hospital setting.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Ambulatory Infusion Therapy Services Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Ambulatory Infusion Therapy Services Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The hospital-based ambulatory surgery centers segment accounts for the highest revenue in type segment of the ambulatory infusion therapy services market in 2023.
Accredo Health, CHI Health, Cleveland Clinic, Coram CVS, HCA Healthcare, McLaren, Option Care Health, PharMerica, and UnitedHealth Group are some of the major players operating in the market.
Asia Pacific region has the highest CAGR of the ambulatory infusion therapy services market.
The Ambulatory Infusion Therapy Services Market is estimated to witness a CAGR of 4.8% from 2023 to 2031
The major factors driving the ambulatory infusion therapy services market are:
1. Shift to Home-Based Care.
2. Growing Demand for Chronic Disease Management.
3. Cost-Effectiveness.
North America region dominated the ambulatory infusion therapy services market in 2023.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ambulatory Surgical Center Market - By Type
1.3.2 Ambulatory Surgical Center Market - By Specialty
1.3.3 Ambulatory Surgical Center Market - By Treatment
1.3.4 Ambulatory Surgical Center Market - By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AMBULATORY SURGICAL CENTER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.3. EXPERT OPINIONS
5. AMBULATORY SURGICAL CENTER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AMBULATORY SURGICAL CENTER MARKET - NORTH AMERICA MARKET ANALYSIS
6.1. AMBULATORY SURGICAL CENTER - NORTH AMERICA MARKET OVERVIEW
6.2. AMBULATORY SURGICAL CENTER - NORTH AMERICA MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AMBULATORY SURGICAL CENTER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HOSPITAL-BASED AMBULATORY SURGERY CENTERS
7.3.1. Overview
7.3.2. Hospital-Based Ambulatory Surgery Centers Market Forecast and Analysis
7.4. FREE-STANDING AMBULATORY SURGERY CENTERS
7.4.1. Overview
7.4.2. Free-Standing Ambulatory Surgery Centers Market Forecast and Analysis
8. AMBULATORY SURGICAL CENTER MARKET - REVENUE AND FORECASTS TO 2028 - SPECIALTY
8.1. OVERVIEW
8.2. SPECIALTY MARKET FORECASTS AND ANALYSIS
8.3. SINGLE- SPECIALTY CENTERS
8.3.1. Overview
8.3.2. Single- Specialty Centers Market Forecast and Analysis
8.4. MULTI-SPECIALTY CENTERS
8.4.1. Overview
8.4.2. Multi-Specialty Centers Market Forecast and Analysis
9. AMBULATORY SURGICAL CENTER MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. CATARACT SURGERY
9.3.1. Overview
9.3.2. Cataract Surgery Market Forecast and Analysis
9.4. ORTHOPAEDIC SURGERY
9.4.1. Overview
9.4.2. Orthopaedic Surgery Market Forecast and Analysis
9.5. ENDOSCOPIC PROCEDURE
9.5.1. Overview
9.5.2. Endoscopic Procedure Market Forecast and Analysis
9.6. GASTROENTEROLOGY
9.6.1. Overview
9.6.2. Gastroenterology Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. AMBULATORY SURGICAL CENTER MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
10.1 NORTH AMERICA AMBULATORY SURGICAL CENTER MARKET OVERVIEW
10.2 NORTH AMERICA AMBULATORY SURGICAL CENTER MARKET FORECASTS AND ANALYSIS
10.3 NORTH AMERICA Ambulatory Surgical Center Market FORECASTS AND ANALYSIS - BY COUNTRIES
10.3.1 United States Ambulatory Surgical Center Market
10.3.1.1 United States Ambulatory Surgical Center Market by Type
10.3.1.2 United States Ambulatory Surgical Center Market by Specialty
10.3.1.3 United States Ambulatory Surgical Center Market by Treatment
10.3.2 Canada Ambulatory Surgical Center Market
10.3.2.1 Canada Ambulatory Surgical Center Market by Type
10.3.2.2 Canada Ambulatory Surgical Center Market by Specialty
10.3.2.3 Canada Ambulatory Surgical Center Market by Treatment
10.3.3 Mexico Ambulatory Surgical Center Market
10.3.3.1 Mexico Ambulatory Surgical Center Market by Type
10.3.3.2 Mexico Ambulatory Surgical Center Market by Specialty
10.3.3.3 Mexico Ambulatory Surgical Center Market by Treatment
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL AMBULATORY SURGICAL CENTER MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. AMBULATORY SURGICAL CENTER MARKET, KEY COMPANY PROFILES
13.1. ASPEN HEALTHCARE
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. REGENT SURGICAL HEALTH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. INTERGRAMED AMERICA INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. HCA HEALTHCARE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MEDICAL FACILITIES CORPORATION
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TH MEDICAL
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AMSURG CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. UNITED SURGICAL PARTNERS INTERNATIONAL
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HEALTHCARE APPRAISERS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SURGERY PARTNERS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Accredo Health
2. CHI Health
3. Cleveland Clinic
4. Coram CVS
5. HCA Healthcare
6. McLaren
7. Option Care Health
8. PharMerica
9. UnitedHealth Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.